Literature DB >> 9116423

Young adults with alpha 1-antitrypsin deficiency identified neonatally: their health, knowledge about and adaptation to the high-risk condition.

T Sveger1, T Thelin, T F McNeil.   

Abstract

The psychological and psychosocial consequences of screening for alpha 1-antitrypsin deficiency (alpha 1 ATD) were investigated when the subjects were 5-7 years old. The present study was conducted when the subjects were 18-20 years old, the foci of interest being their health, psychosomatic problems, knowledge about alpha 1 ATD and the potential effect of that knowledge on their lives and future family planning. Samples of 61 PiZ and 61 demographically matched control subjects, 18-20 years old, were asked to participate. Written, structured questionnaires covered the following items: basic familial characteristics, psychosomatic symptoms, opinions on medical check-ups, information and views on future alpha 1 ATD screening, whether the knowledge about alpha 1 ATD had affected the life and family planning of alpha 1 ATD individuals. Items concerning the "alpha 1 ATD matter" were excluded in the questionnaires given to the controls. Questionnaire data were obtained from 50 alpha 1 ATD and 48 control individuals, 41 of each being matched alpha 1 ATD-control pairs. No significant differences were found in demographic or educational backgrounds, psychosomatic complaints such as headache, sleep difficulties, stomach ache, tiredness or anxiety. Lung symptoms occurred more frequently in alpha 1 ATD subjects (p = 0.05). Six per cent of the alpha 1 ATD individuals planned working careers with a high risk of air pollution. The majority (86%) of the alpha 1 ATD subjects perceived the contact with the medical services as positive; 14% as both positive and negative. The information concerning alpha 1 ATD was assessed as satisfactory by 73%, as both good and bad by 17% and as unsatisfactory by 10%. All alpha 1 ATD subjects advocated general screening for alpha 1 ATD, the neonatal period being chosen as optimal by 94%. Half of the alpha 1 ATD individuals thought that the knowledge of their high-risk condition had affected their lives, particularly their awareness of the dangers of smoking and environmental pollution. The majority, 88%, knew that they should avoid smoking to protect their lungs. In conclusion, no negative psychosocial consequences of the neonatal alpha 1 AT-screening were found in early adulthood. The alpha 1 ATD individuals were aware of the dangers of smoking and were of the opinion that alpha 1 AT-screening should be recommended.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9116423     DOI: 10.1111/j.1651-2227.1997.tb08828.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

1.  Clinical utility gene card for: α-1-antitrypsin deficiency.

Authors:  Sabina Janciauskiene; Ilaria Ferrarotti; Florian Laenger; Danny Jonigk; Maurizio Luisetti
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 2.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

3.  Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease.

Authors:  Amy Feldman; Ronald J Sokol
Journal:  Lung Health Prof Mag       Date:  2013

4.  Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension.

Authors:  Jeffrey H Teckman; Philip Rosenthal; Robert Abel; Lee M Bass; Sonia Michail; Karen F Murray; David A Rudnick; Daniel W Thomas; Cathie Spino; Ronen Arnon; Paula M Hertel; James Heubi; Binita M Kamath; Wikrom Karnsakul; Kathleen M Loomes; John C Magee; Jean P Molleston; Rene Romero; Benjamin L Shneider; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

Review 5.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

Review 6.  Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management.

Authors:  Jeffrey H Teckman; Douglas Lindblad
Journal:  Curr Gastroenterol Rep       Date:  2006-02

7.  Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency.

Authors:  N Seersholm; A Kok-Jensen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

8.  Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.

Authors:  Badr Aljarallah; Ahmed Ali; Moataz Dowaidar; Ahmad Settin
Journal:  Saudi J Gastroenterol       Date:  2011 Jul-Aug       Impact factor: 2.485

9.  Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension.

Authors:  Jeffrey Teckman; Philip Rosenthal; Kieran Hawthorne; Cathie Spino; Lee M Bass; Karen F Murray; Nanda Kerkar; John C Magee; Saul Karpen; James E Heubi; Jean P Molleston; Robert H Squires; Binita M Kamath; Stephen L Guthery; Kathleen M Loomes; Averell H Sherker; Ronald J Sokol
Journal:  J Pediatr       Date:  2020-07-11       Impact factor: 6.314

Review 10.  Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management.

Authors:  Jan Stolk; Niels Seersholm; Noor Kalsheker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.